期刊文献+

芎冰微乳不同给药方式的兔体内药动学研究 被引量:1

Pharmacokinetics of Xiongbing Microemulsion in Rabbit with Different Routes of Administration
原文传递
导出
摘要 目的:研究芎冰微乳中川芎嗪(TMP)以ig、iv2种不同给药方式在兔体内的药动学特性。方法:芎冰微乳分别ig和iv给药后,采用高效液相色谱法测定不同时间点TMP的血药浓度,用DAS2.1数据处理软件计算药动学参数。结果:TMP对照品检测浓度在0.062~6.200μg·mL-1范围内与其峰面积积分值呈良好线性关系。ig、iv给予TMP在体内药动学过程均符合二室模型,其主要药动学参数如下:t1/2α分别为7.618、2.842min,t1/2β分别为56.417、20.318min,V分别为3.161、0.411L·kg-1,Cl分别为0.069、0.027L·min-1·kg-1,AUC(0~∞)分别为55594.712、149207.814μg·min·L-1,MRT(0~∞)分别为76.356、24.805min;ig给药绝对生物利用度为37.26%。结论:芎冰微乳ig给药消除较慢,在体内滞留时间较长,但绝对生物利用度较低;而iv给予TMP分布迅速,但代谢也较快,体内作用时间较短,不利于药物的疗效发挥。 OBJECTIVE:To investigate pharmacokinetic characteristics of ligustrazine(tetramethylpyrazine as chemical name,TMP) in rabbit after intragastric(i.g.) and intravenous(i.v.) administration of Xiongbing microemulsion.METHODS:The plasma concentration of TMP was determined by HPLC after i.g.and i.v.administration.The data were processed by DAS 2.1 software to calculate the pharmacokinetic parameters.RESULTS:The linear range of TMP was 0.062-6.200 μg·mL-1.The pharmacokinetics of TMP was fitted to two compartment model after i.g.and i.v administration.The main pharmacokinetic parameters for TMP were as follow:t1/2α were 7.618 min vs.2.842 min,t1/2β were 56.417 min vs.20.318 min,V were 3.161 L·kg-1 vs.0.411 L·kg-1,Cl were 0.069 L·min-1·kg-1 vs.0.027 L·min-1·kg-1,AUC(0-∞) were 55 594.712 μg·min·L-1 vs.149 207.814 μg·min·L-1,MRT(0-∞) were 76.356 min vs.24.805 min.The absolute bioavailability of TMP was 37.26% after i.g.administration.CONCLUSION:TMP distribute slowly with i.g.administration and the mean residence time is long,while the absolute bioavailability is relatively low.On the contrary,TMP distributed rapidly with i.v.administration.There are rapid metabolism and short duration,which is not good for the efficacy of drugs.
出处 《中国药房》 CAS CSCD 北大核心 2011年第27期2500-2502,共3页 China Pharmacy
基金 国家自然科学基金资助项目(30873443) 广东省科技计划项目(2010B030700039)
关键词 芎冰微乳 药动学 高效液相色谱法 给药途径 Xiongbing microemulsion Pharmacokinetic HPLC Route of administration
  • 相关文献

参考文献6

二级参考文献52

  • 1黄志力,桂常青,孙瑞元.盐酸川芎嗪在大鼠体内的分布[J].中国药理学通报,1994,10(4):297-300. 被引量:18
  • 2韩冬,班春林,崔黎丽,李国栋.微透析技术及在药学中的应用进展[J].药学实践杂志,2005,23(3):139-142. 被引量:3
  • 3王勇,张忠义,徐峰,王秉均,张守尧.冰片对川芎嗪血药浓度和在脑中分布的影响[J].中国药业,2006,15(1):30-31. 被引量:27
  • 4舒冰,周重建,马迎辉,王拥军,施杞.中药川芎中有效成分的药理作用研究进展[J].中国药理学通报,2006,22(9):1043-1047. 被引量:246
  • 5国家基本药物领导小组.新药(西药)临床研究指导原则汇编[M].北京:人民卫生出版社,1999.620.
  • 6Lawrence M J, Gareth D R. Mieroemulsion-based media as novel drug delivery systems [J]. Adv Drug Deliv Rev, 2000, 45: 89-121.
  • 7MeCord JM.Oxygen-derived free radicals in post isehemic tissue injury[J].New Eng J Med,1985,312(3):159.
  • 8Lipton SA,Choi YB,Pan ZⅡ,et al.A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitrosocompounds[J].Nature,1993,36(4):626.
  • 9Zea Longa E,Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke,1989,20:84-91.
  • 10Weiss SJ.Oxygen,ischemia and inflammation[J].Acta Physial Scand,1986,128(Suppl 548):9-37.

共引文献72

同被引文献23

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部